Back to search results

Caris Biorepository Research Protocol

This study is creating a collection of human biological samples (like tissue or blood) and health information, called a biorepository. This collection will help researchers learn more about cancer, how to find it early, and how to treat it. The goal is to make these samples and data available for many research studies over the next 35 years to advance precision medicine (medical care tailored to you) and improve patient care. You can join if you are 18 years or older and can give informed consent (understand and agree to participate). The study is currently collecting samples, but the exact status is unclear.

Study design
This is an observational study, meaning researchers will collect information without giving any specific treatments. The study plans to enroll 100,000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The biorepository aims to be developed and specimens released for testing over a period of 35 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01499394

Caris Biorepository Research Protocol

Recruiting
Not specifiedAges 18+Observational
Caris Science, Inc.
~100,000 participants
Updated 2026-01-21 on ClinicalTrials.gov

At a glance

Recruiting sites
38 of 38 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.
Measured over 35 years
+1 more outcome measured

Conditions

Cancer
Early Detection of Cancer
Minimal Residual Disease

Explore related trials

Malignant Neoplasm

Where it's being run

38 sites across 20 states
Florida5
Georgia4
Arkansas3
Louisiana3
Mississippi3
Maryland2
New York2
Ohio2

Study leadership

  • Matthew Oberley, MD · PRINCIPAL_INVESTIGATOR · Caris Life Sciences

Who to contact

Mary Baker
[email protected]
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age or older
Capacity to provide informed consent

Exclusion

Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository.
Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults.
Individuals who lack the capacity to give informed consent

What this trial measures

  • Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.35 years

    Retention of biospecimen samples with DNA

  • Implement release of specimens from biorepository for testing35 years

    Research for the purposes of cancer laboratory diagnostic tests.